Once touted as a COVID-19 'game changer,' Paxlovid is now a question mark for clinicians

By WNews 1 Min Read

This story is part of CBC Health’s Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven’t subscribed yet, you can do that by clicking here.

If you catch the virus behind COVID-19 and you’re at a high risk of serious illness, there’s one major tool in a physician’s arsenal to keep you out of hospital: Paxlovid.

Pfizer’s antiviral drug was hailed as life-saving when it burst onto the scene midway through the pandemic. Clinical trials, conducted on people who’d never been vaccinated, showed it protected those vulnerable individuals from becoming dangerously sick, with a nearly

- Advertisement -
Share This Article
By WNews
Follow:
WNews bring the latest news in an objection, balance and honest.
Leave a comment
Reading: Once touted as a COVID-19 'game changer,' Paxlovid is now a question mark for clinicians

(C) 2012 – 2024  | WNews Broadcasting Corp, a W-World Company | All Rights Reserved

Connect
with Us

Report a Error with this Story

Notice a error or facts with this story, please submit the information below and someone from our newsroom will review it and change if required